Dynavax Technologies Corporation has announced the pricing of a previously announced underwritten public offering of 4,545,455 shares of its common stock, offered at a price to the public of $27.50 per share. The gross proceeds to Dynavax from this offering are expected to be approximately $125 million, before deducting the underwriting discount and other estimated offering expenses […]
News: Dynavax Prices Equity Offering $DVAX Read More »
Fibrocell Science, Inc., an autologous cell and gene therapy company, has announced the pricing of its Equity Offering. The firm has announced the pricing of an underwritten public offering of 2.6 million shares of its common stock at a price of $5.80 per share. Gross proceeds will be approximately $13.6 million, after deducting underwriting discounts and commissions
News: Fibrocell Equity Offering $FCSC Read More »
Vascular Solutions, Inc.has reported financial results for the second quarter ended June 30, 2015. Fiscal Q2 2015 Highlights vs. Same Year-ago Quarter Worldwide revenue increased 22% from 2014 to $37.6 million, Revenue guidance range of $35.5 million to $36.5 million US Revenue increased 14% to $28.7 million, International revenue increased 60% to $8.9 million Adjusted EPS increased
Earnings: Vascular Solutions Revenues Up $VASC Read More »
Johnson & Johnson Inc. has announced the Dividends fore the third quarter of FY-2015-16. Amount is $0.75 per share on the company’s common stock. and payable by September 8th 2015. Johnson & Johnson is Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. View the full release here.
News: Johnson & Johnson Announces Dividends $JNJ Read More »
Histogenics Corporation, a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, announced the appointment of Dr. Gloria Matthews, DVM, Ph.D., DAVCS, as its Chief Medical Officer. Dr. Matthews brings more than 20 years of global research, development and surgical experience in orthopedics and cartilage repair to Histogenics, and in her
News: Gloria the New CMO at Histogenics $HSGX Read More »
